
One of the most successful spin out companies, based at the London School of Pharmacy had discovered an amazing gene targeting technique. A day in the lab taught us that using SP-2001, cancer cells could be identified by their DNA code, these cells were highlighted and 'switched off'.
They needed second round funding, to get through trials and to license the technology.
The identity got an overhaul, more evolution than revolution. A new stand, marketing materials and more importantly, the website got the technology in front of the people that mattered.
SP-2001 has been licensed in the USA and is in Phase 1 clinical trials. We continue to watch wide eyed as the technology progresses as well as making sure everybody knows about it.
Leading in DNA-targeting. A hugely successful biomedical spin out company, partly funded by Cancer Research.
Cultivate identity
UCL BioMedica identity
Navig8's portfolio demonstrated an agency that listens and captures the essence of an organization. Just what we wanted!
Andrea Mason
Anouska Hempel Design